Why Research Only Peptides?
Not for human Consumption..
The "not for human consumption" label on research peptides is primarily due to regulatory and economic hurdles, not inherent safety concerns. Here's a quick look at why:
​
-
FDA Approval Costs: Obtaining FDA approval is incredibly expensive, costing millions of dollars. This is a significant barrier for most peptide companies, unlike large pharmaceutical corporations with vast resources.
​
-
Pricy Research Trials: Required preclinical and clinical trials also cost hundreds of thousands to millions. While studies often show peptides are safe and effective, they usually don't meet the FDA's extensive requirements, making these trials largely unaffordable for smaller companies.
​
-
Patent Issues: Many peptides are derived from naturally occurring proteins, making them ineligible for patents. This reduces their appeal to profit-driven pharmaceutical companies.
​
-
Off-Label Prescriptions: Doctors frequently prescribe FDA-approved drugs for unapproved ("off-label") uses. This creates competition for peptides and further discourages investment from large pharmaceutical firms.​
​
Despite these challenges, reputable peptide suppliers prioritize customer safety. They rigorously test all batches for purity and sterility through independent third-party labs before distribution, offering a reliable alternative to often overpriced pharmaceutical options.
